1Caillat J, Flahault A, De Barbeyrac B, et al. Community epidemiology of ctdanmydiae pneumoniae in LRT1 in France over 29 months. Eur Epidemiol, 2005, 20(7): 643- 651.
2Macfarlane J, Holmes W, Gard P, et al. Prespe ctive study of the incidence, actiology and outcome of adult lower respiratory tract illness in the community . Thorax, 2001, 56(2): 109-114.
3Nagalingam NA, Adesiyon AA, Swanalon WH, et al. Prevalance of mycoplasma pneumoniae and chlamydia pneumonia patients in four major hospitals in Trinidad. New Microbiol, 2004, 27(4): 345 - 351.
6Rastawicki W, Kaluz ewski S, Jagielski M, et al. Epidemiology of mycoplasma pneumoniae in poland:28 years of surveillance in warsaw 1970- 1997. Eur Surveill, 1998,3(10) :99 - 100.
7Yu J, Yoo Y, Kim do K, et al. Distribution of antibody titers to mycoplasma pneumoniae in korean children in 2000 - 2003. J Korean Med Sci, 2005, 20 (4) : 542 - 547.
8Lind K, Bentzon MW.Ten and a half years seroepidemiology of mycoplasma peumoniae infection in Denmark. Epidemiol Infect, 1991,107(2) : 189 199.
10Maltezou HC, La - Scola B, Astra H, et al. Mycoplasma pneumoniae and legionella pneumophila in community - acquired lower respiratory tract infections among hospitalized children : Diagnosis by real time PCR. Scand J Infect Dis,2004,36(9) :639 - 642.
2[1]Gaydos CA,Quinn TC ,Eiden JJ.Identification of Chlamydia pneumoniae by DNA amplification of the 16SrRNA gene[J]. J Clin Microbiol, 1992, 30:796-800
3[2]Ieven M,Ursi D, van Bever H, et al.Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M.pneumoniae in acute respiratory tract infections in pediatric patients[J]. J Infect Dis,1996, 173:1445-1452
4[3]Darelid J,Lofgren S,Malmvall BE,et al.Legionella pneumophila serogroup 1 antibody kinetics in patients with Legionnaires' disease:implications for serological diagnosis[J]. Scand J Infect Dis, 2003, 35:15-20
5[4]Jokinen C, Heiskanen L, Juvonen H,et al.Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland[J]. Clin Infect Dis, 2001, 32:1141-1154
6[5]Principi N, Esposito , Blasi F,et al.Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections[J]. Clin Infect Dis, 2001, 32:1281-1289
7[6]Gotfried MH.Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting:results from the 1999-2000 respiratory surveillance program[J]. Am J Med,2001, 111(Suppl): 25S-29S
8[7]Dorigo-Zetsma JW,Zaat SA, Wertheim-van Dillen PM,et al.Comparison of PCR,culrure,and serological tests for diagnosis of Mycoplasma pneumoniae respireatory tract infection in children[J]. J Clin Microbiol,1999, 37:14-17
9Principi N, Esposito S, Blasi F, et al. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired lower respiratory tract infections [J]. Clin Infect Dis,2001,30(9) :1 281.
10Thibodeau KP, Viera AJ. Atypical pathogens and challenges in community-acquired pneumonia [ J ]. Am Fam Physician, 2004,69 ( 7 ) :1 699-1 706.
7Tuuminen T,Varjo S,Ingman H,et al.Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae mmunoglobulin G and A antibodies in a healthy Finnish population as analysed by quantitative enzyme immunoassays[J].Clin Diagn Lab Immunol,2000,7(5):734-738.
8Tuuminen T,Varjo S,Ingman H ,et al. Prevalence of Chlamydia pneu- moniae and Mycoplasma pneumoniae mmunoglobulin G and A antibod- ies in a healthy Finnish population as analysed by quantitative enzyme immunoassays [ J ]. Clin Diagn Lab Immunol,2000,7 (5) :734 - 738.
9Loens K, Ieven M,Ursi D, et al. Detection of Mycoplasma pneumoni- ae by real - time nucleic acid sequence - based amplification [ J ]. J Clin Microbiol,2003,41 ( 9 ) :4448 - 4450.
10Honda J,Yano T,Kusaba M,et al. Clinical use of capillary PCR to di- agnose Mycoplasma pneumonia [ J ]. J Clin Microbiol, 2000,38 ( 4 ) : 1382 - 1384.
